Stocks and Investing Stocks and Investing
Thu, March 28, 2024

Gary Nachman Initiated (AQST) at Buy and Held Target at $7 on, Mar 28th, 2024


Published on 2024-10-28 09:58:35 - WOPRAI, Gary Nachman
  Print publication without navigation


Gary Nachman of Raymond James, Initiated "Aquestive Therapeutics, Inc." (AQST) at Buy and Held Target at $7 on, Mar 28th, 2024.

Gary has made no other calls on AQST in the last 4 months.



There are 4 other peers that have a rating on AQST. Out of the 4 peers that are also analyzing AQST, 0 agree with Gary's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Gary


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $9 on, Monday, March 18th, 2024
  • Jason Butler of "JMP Securities" Maintained at Buy with Increased Target to $10 on, Friday, March 15th, 2024
  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $9 on, Thursday, March 7th, 2024
  • Thomas Flaten of "Lake Street" Maintained at Strong Buy with Increased Target to $8 on, Thursday, March 7th, 2024

Contributing Sources